Enzo BioChem has agreed to a $4.5 million settlement with New Jersey, New York and Connecticut over its alleged deficient data and security safeguards, which led to a 2023 ransomware attack that compromised the personal health data of 2.4 million patients, including about 331,600 New Jersey residents.